Immunization News and Research

RSS
Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Antigenic imprinting of sarbecovirus

Antigenic imprinting of sarbecovirus

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Sinopharm's candidate SARS-CoV-2 vaccine BBIBP-CorV shows promise in clinical trials

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Rapid development of functionally diverse SARS-COV-2 mouse monoclonal antibodies

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

Sanofi Translate Bio MRT5500 COVID-19 vaccine shows promise in preclinical trials

Nasal spray COVID-19 vaccine shows promising results in mice

Nasal spray COVID-19 vaccine shows promising results in mice

Peer reviewers flag misleading studies on COVID-19

Peer reviewers flag misleading studies on COVID-19

Temporal predictors of SARS-CoV-2 antibodies

Temporal predictors of SARS-CoV-2 antibodies

Study explains the fractal nature of COVID-19 transmission

Study explains the fractal nature of COVID-19 transmission

Study estimates lower herd immunity to SARS-CoV-2 in the U.S.

Study estimates lower herd immunity to SARS-CoV-2 in the U.S.

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

Researchers hope to develop an effective COVID-19 vaccine using bovine adenovirus

Researchers hope to develop an effective COVID-19 vaccine using bovine adenovirus

Study shows COVID-19 vulnerability increases exponentially with age

Study shows COVID-19 vulnerability increases exponentially with age

HPV vaccination mandates did not improve rates of HPV vaccine series completion, shows study

HPV vaccination mandates did not improve rates of HPV vaccine series completion, shows study

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Production of six monoclonal antibodies against SARS-CoV-2 spike protein

Less than 10% of US adults have SARS-CoV-2 antibodies

Less than 10% of US adults have SARS-CoV-2 antibodies

Supporting Coronavirus Research with Liquid Chromatography

Supporting Coronavirus Research with Liquid Chromatography

Newly developed fusion protein could improve COVID-19 research

Newly developed fusion protein could improve COVID-19 research

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial